---
title: "BrainStorm names ex-FDA official Peter Pitts executive chairman, Frenkel becomes senior adviser"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294416440.md"
description: "BrainStorm Cell Therapeutics appointed former FDA official Peter Pitts as executive chairman and chief strategic regulatory and policy officer, granting him leadership over strategy, partnerships, and the upcoming NurOwn Phase 3b trial. Concurrently, Board Chairman Jacob Frenkel is stepping down to serve as a senior adviser as the company transitions into late-stage clinical execution."
datetime: "2026-07-30T21:08:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294416440.md)
  - [en](https://longbridge.com/en/news/294416440.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294416440.md)
---

# BrainStorm names ex-FDA official Peter Pitts executive chairman, Frenkel becomes senior adviser

-   BrainStorm Cell Therapeutics named former FDA Associate Commissioner Peter J. Pitts executive chairman, adding the title of chief strategic regulatory and policy officer. \* Pitts takes day-to-day leadership of strategy, partnerships, investor engagement, clinical planning, with a mandate to run the upcoming NurOwn Phase 3b trial. \* Board Chairman Jacob Frenkel will step down into a senior adviser role as the company shifts into late-stage clinical execution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brainstorm Cell Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-088728), on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BCLI.US](https://longbridge.com/en/quote/BCLI.US.md)

## Related News & Research

- [Pi Network price prediction 2026–2032: Will PI recover after its all-time low?](https://longbridge.com/en/news/294609083.md)
- [Repligen says BioLife deal targets Q4 close pending regulatory, shareholder approvals](https://longbridge.com/en/news/294739855.md)
- [08:13 ETNew XYZ-Tip-Tilt Air Bearing Stage, from PI](https://longbridge.com/en/news/294822312.md)
- [Volaris director Ricardo Maldonado Yanez files initial beneficial ownership statement](https://longbridge.com/en/news/294435358.md)
- [CytomX Therapeutics director Charles S. Fuchs files initial beneficial ownership statement](https://longbridge.com/en/news/294418612.md)